E2F1-/- C57BL/6 mice overexpressing a human Bcl-2 transgene in B cells develop a mild autoimmune syndrome

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 156-165

  Marín, María J ^a   García, Itxaso ^b   Peña, Marta ^a   Bolívar, Ainhoa ^a   Zubiaga, Ana ^b   López Hoyos, Marcos ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Apoptosis; Autoimmune syndrome; Bcl 2; Cell cycle; E2F; Mice

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN BCL 2; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD SAMPLING; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CROSS BREEDING; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE OVEREXPRESSION; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOLOGICAL TOLERANCE; KIDNEY INJURY; KNOCKOUT MOUSE; MALE; MESANGIUM CELL; MICROSCOPY; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSGENE; TRANSGENIC MOUSE;

EID: 25444458011     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.057     Document Type: Conference Paper

References (25)

1. WOO, M.J. et al. 2003. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat. Immunol. 4: 1016-1022.
2. CAO, Q. et al. 2004. The E2F-1 transcription factor promotes caspase-8 and Bid expression, and enhances Fas signaling in T cells. J. Immunol. 173: 1111-1117.
3. SALMENA, L. et al. 2003. Essential role for caspase-8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17: 883-895.
4. KOVESDI, I., R. REICHEL & J.R. NEVINS. 1987. Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc. Natl. Acad. Sci. USA 84: 2180-2184.
5. DYSON, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245-2262.
6. HELIN, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genes Dev. 8: 28-35.
7. PHILLIPS, A.C. & K.H. VOUSDEN. 2001. E2F-1 induced apoptosis. Apoptosis 63: 173-182.
8. MORONI, M.C. et al. 2001. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3: 552-558.
9. LISSY, N.A. et al. 2000. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407: 642-645.
10. IRWIN, M. et al. 2000. Role for the p53 homologue p73 in E2F-1 induced apoptosis. Nature 407: 645-648.
11. ZHU, J.W. et al. 1999. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ. 10: 829-838.
12. GARCIA, I. et al. 2000. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11: 91-98.
13. CHAO, D.T. & S.J. KORSMEYER. 1998. Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 16: 395-419.
14. O'REILLY, L.A., D.C.S. HUANG & A. STRASSER 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15: 6979-6990.
15. VAIRO, G. et al. 2000. Bcl-2 retards cell cycle entry through p27kip1, pRB relative p130, and altered E2F regulation. Moll. Cell. Biol. 20: 4745-4753.
16. LOPEZ-HOYOS, M. et al. 1996. Constitutive expression of Bcl-2 in B cells causes a lethal form of lupuslike autoimmune disease after induction of neonatal tolerance to H-2b alloantigens. J. Exp. Med. 183: 2523-2531.
17. MARQUINA, R. et al. 2004. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand White x C57BL/6)F1-bcl-2 transgenic mice. J. Immunol. 172: 7177-7185.
18. STRASSER, A. et al. 1991. Enforced Bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88: 8661-8665.
19. KONO, D.H., R. BACCALA & A.N. THEOFILOPOULOS. 2004. Genes and genetics of murine lupus. In Systemic Lupus Erythematosus. R.G. Lahita, Ed.: 225-263. Elsevier. London.
20. LANG, J. et al. 1997. Enforced Bcl-2 expression inhibits antigen-mediated elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive immature B cells. J. Exp. Med. 186: 1513-1522.
21. SMITH, K.G.C. et al. 2000. Bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J. Exp. Med. 191: 475-484.
22. OPFERMAN, J.T. & S.J. KORSMEYER. 2003. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4: 410-415.
23. VAN PARIJS, L., A. BIUCKIANS & A.K. ABBAS. 1998. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 160: 2065-2071.
24. MOSMANN, T.R. & S. SAD. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146.
25. INFANTE, A. et al. 2004. Altered Th1 and Th2 responses in E2F1- and E2F2-deficient mice. Presented at the 12th International Congress of Immunology. Montreal, July 21, 2004.